RxDoctor Payments DataLook up a doctor →

Alexa Hetzel, PA

Physician Assistant · East Windsor, NJNPI 1851887301

Payments from drug & device makers

$750,108in general payments, 2019–2025

Across 1,945 payments — averaging $385.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$107K
  • AbbVie$101K
  • Johnson & Johnson$89K
  • Sanofi US Services Inc.$75K
  • Janssen Research & Development, LLC$69K
  • UCB, Inc.$67K
  • plus $242K from 27 others

What the payments were for

  • Consulting fees$119,96620%
  • Speaking & faculty fees$392,49267%
  • Travel & lodging$44,6918%
  • Food & beverage$29,2435%
  • Education$1,3580%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$750,108 in reported general payments places this provider in the 95th percentile of 2,726 physician assistant providers in New Jersey.

See all physician assistant providers in New Jersey

Medicare billing

Part B allowed, 2024
$418,348
Medicare patients
364
Services billed
4,204

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RinvoqUpadacitinib16$96,406
Enbrel SureclickEtanercept13$92,853
Dupixent SyringeDupilumab25$89,013
Dupixent PenDupilumab11$41,665
OpzeluraRuxolitinib Phosphate12$23,497
Clobetasol Propionate80$3,246
Triamcinolone Acetonide68$962
Metronidazole17$733
Fluorouracil15$725
Ketoconazole44$654
ValacyclovirValacyclovir Hcl11$373
Fluticasone Propionate21$325
Doxycycline Hyclate18$155
Mupirocin21$136
Hydroxyzine Hcl13$84

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$101,326$96,40616 claims
Incyte CorporationOpzelura$28,014$23,49712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,726 physician assistant providers in New Jersey.

Other physician assistant in East Windsor

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →